Morbus Fabry of the heart: Why should cardiologists care?

Zeitschrift fur Kardiologie

Volumn 94, Issue 9, 2005, Pages 557-563

  Strotmann, J ^a   Weidemann, F ^a   Breunig, F ^a   Knoll, A ^a   Wanner, C ^a   Ertl, G ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Cardiomyopathy; Enzyme replacement therapy; Fabry disease; Heart failure

Indexed keywords

AGALSIDASE ALFA; AGALSIDASE BETA; ALDOSTERONE ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CERAMIDE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLYCOSPHINGOLIPID; NITRATE;

ANGINA PECTORIS; ARTICLE; ATRIOVENTRICULAR BLOCK; CLINICAL FEATURE; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE CARRIER; DISEASE COURSE; DIZZINESS; ENZYME REPLACEMENT; FABRY DISEASE; FATIGUE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART SURGERY; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPOTENSION; INCIDENCE; LYSOSOME STORAGE DISEASE; PACEMAKER; PERCUTANEOUS CORONARY INTERVENTION; PR INTERVAL; PROGNOSIS; VALVULAR HEART DISEASE; X CHROMOSOME LINKED DISORDER;

EID: 24644440096     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-005-0284-4     Document Type: Article

References (0)